Zarzuelo Romero et al., 2021
ViewHTML| Publication | Publication Date | Title |
|---|---|---|
| Lobbous et al. | An update on neurofibromatosis type 1-associated gliomas | |
| Li et al. | Mitochondrial DNA variants and common diseases: a mathematical model for the diversity of age-related mtDNA mutations | |
| Li et al. | Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis | |
| Wahnschaffe et al. | JAK/STAT-activating genomic alterations are a hallmark of T-PLL | |
| Zarzuelo Romero et al. | Therapeutic value of single nucleotide polymorphisms on the efficacy of new therapies in patients with multiple sclerosis | |
| Coppedè et al. | Association of polymorphisms in genes involved in one-carbon metabolism with MTHFR methylation levels | |
| Crisà et al. | Atypical chronic myeloid leukemia: where are we now? | |
| Barbato et al. | Integrated genomics identifies miR-181/TFAM pathway as a critical driver of drug resistance in melanoma | |
| Kim et al. | Osteosarcoma in pediatric and adult populations: are adults just big kids? | |
| Funk et al. | BAX redistribution induces apoptosis resistance and selective stress sensitivity in human HCC | |
| Contadini et al. | Caspase-8 and tyrosine kinases: a dangerous liaison in cancer | |
| O’Cathail et al. | NRF2 mediates therapeutic resistance to chemoradiation in colorectal cancer through a metabolic switch | |
| Nguyen et al. | H3G34-mutant gliomas—A review of molecular pathogenesis and therapeutic options | |
| Inoue et al. | Roles of the PARP inhibitor in BRCA1 and BRCA2 pathogenic mutated metastatic prostate cancer: direct functions and modification of the tumor microenvironment | |
| Huber et al. | Association of human FOS promoter variants with the occurrence of knee-osteoarthritis in a case control association study | |
| Mijit et al. | Identification of novel pathways regulated by APE1/Ref-1 in human retinal endothelial cells | |
| Puca et al. | Cellular and molecular determinants of biologic drugs resistance and therapeutic failure in inflammatory bowel disease | |
| Illini et al. | Mobocertinib in patients with EGFR exon 20 insertion-positive non-small cell lung cancer (MOON): An international real-world safety and efficacy analysis | |
| Ahn et al. | 3′-UTR polymorphisms of MTHFR and TS associated with osteoporotic vertebral compression fracture susceptibility in postmenopausal women | |
| Simões et al. | The road so far in colorectal cancer pharmacogenomics: are we closer to individualised treatment? | |
| Sugaya | Clinical guidelines and new molecular targets for cutaneous lymphomas | |
| Passariello et al. | PATZ1 is overexpressed in pediatric glial tumors and correlates with worse event-free survival in high-grade gliomas | |
| Liu et al. | IMPDH Inhibition decreases TERT expression and synergizes the cytotoxic effect of Chemotherapeutic agents in Glioblastoma Cells | |
| Desilets et al. | Upfront DPYD genotyping and toxicity associated with fluoropyrimidine-based concurrent chemoradiotherapy for oropharyngeal carcinomas: a work in progress | |
| Custódio et al. | Expression profiling in ovarian cancer reveals coordinated regulation of brca1/2 and homologous recombination genes |